Thyroid Autoantibodies in Type -1 Diabetic Mellitus Patients and their Correlation with Thyroid function and Tumor Necrotic Factor-Alpha
DOI:
https://doi.org/10.25271/sjuoz.2023.11.1.1013Keywords:
Type-1 Diabetic Mellitus, autoimmune thyroid antibodies, TNF-αAbstract
Type 1 Diabetes Mellitus (T1DM) is a complicated autoimmune disorder initiated by T-cell-mediated damage of pancreatic beta cells, resulting in insulin deficiency and the development of hyperglycaemia. This disease is most common in childhood and adolescence and frequently co-occurs with other autoimmune conditions like autoimmune thyroiditis. This work aimed to investigate thyroid autoantibodies and their correlation with thyroid functions and tumour necrosis factor-alpha (TNF-α) in T1DM patients. Eighty participants were enrolled in a case-control study, including sixty T1DM patients and twenty healthy controls. Peripheral blood specimens were taken from individuals with proven T1DM and healthy individuals (control group). Body mass index (BMI), fasting blood sugar (FBS), glycated hemoglobulin (HbA1c), thyroid-stimulating hormone (TSH), free triiodothyronine (FT3), free thyroxine (FT4), thyroid autoantibodies, including anti-thyroid peroxidase (anti-TPO) in addition to anti-thyroglobulin (anti-Tg), and TNF- α concentrations were evaluated in T1DM and control groups. Our findings revealed that thyroid autoantibodies were significantly more prevalent in T1DM patients, elevated TSH, and significantly higher TNF-α levels than in the control group, indicating an increased risk for inflammation based on cytokine levels. The current study proved that in T1DM patients' sera compared to the healthy control, thyroid autoantibodies and TNF-α levels were positively correlated. In conclusion, poor diabetes management and high TSH levels may indicate subclinical hypothyroidism, which impacts diabetes control. This is possibly linked to thyroid autoimmunity. Future research is needed to understand how TNF- αcontributes to the progression of diabetes disease and its complications.
References
Popławska-Kita, A., Siewko, K., Szpak, P., Król, B., Telejko, B., Klimiuk, P. A., Stokowska, W., Górska, M. & Szelachowska, M. (2014). Association between type 1 diabetes and periodontal health. Advances in Medical Sciences, 59, 126-131. https://doi.org/10.1016/j.advms.2014.01.002
Qiao, Y.-c., Chen, Y.-l., Pan, Y.-h., Tian, F., Xu, Y., Zhang, X.-x. & Zhao, H.-l. (2017). The change of serum tumor necrosis factor alpha in patients with type 1 diabetes mellitus: A systematic review and meta-analysis. PloS one, 12, e0176157. https://doi.org/10.1371/journal.pone.0176157
Ridha, M. F. & Al Zubaidi, M. A. (2019). Thyroid auto immune antibodies in children with Type-I Diabetes mellitus in relation to diabetes control. Pakistan Journal of Medical Sciences, 35, 969. https://doi.org/10.12669/pjms.35.4.192
Seyfarth, J., Förtsch, K., Ahlert, H., Laws, H. J., Karges, B., Deenen, R., Köhrer, K., Mayatepek, E., Meissner, T. & Jacobsen, M. (2017). Dominant TNFα and impaired IL‐2 cytokine profiles of CD4+ T cells from children with type‐1 diabetes. Immunology and cell biology, 95, 630-639. https://doi.org/10.1038/icb.2017.24
Shani, W. S., Shnawa,B. H., &Waheda, N. E. (2012). Levels of Immunoglobulins and complements in sera of patients with toxoplasmosis. Basrah Journal of Scienec (B) Vol, 30, 72-77.
Shiva, S. & Behbahani, A. (2009). Autoimmune thyroid disease in children and adolescents with type 1 diabetes mellitus in Northwest Iran. Saudi Med J, 30, 673-6.
Shnawa, B. H., Al-Ali, S. J., Ahmad, H. F. & Essa, S. A. (2020). An Investigative Study of Smoking Effects on IL-31 Levels and Leukocyte differential counts in Humans. Annals of Tropical Medicine and Public Health, 23, 23-1133. https://doi.org/10.36295/asro.2020.231133
Silva, L. B., dos Santos Neto, A. P., Maia, S. M., dos Santos Guimarães, C., Quidute, I. L., Carvalho, A. d. A., Júnior, S. A. & Leão, J. C. (2019). The role of TNF-α as a proinflammatory cytokine in pathological processes. The Open Dentistry Journal, 13. http://dx.doi.org/10.2174/1874210601913010332
Swaroop JJ, Rajarajeswari D, Naidu JN.(2012). Association of TNF-α with insulin resistance in type 2 diabetes mellitus. Indian J Med Res. 135(1):127-30. doi: 10.4103/0971-5916.93435.
Szabo, C. E., Man, O. I., Istrate, A., Kiss, E., Catana, A., Creț, V., Șerban, R. S. & Pop, I. V. (2020). Role of adiponectin and tumor necrosis factor-alpha in the pathogenesis and evolution of type 1 diabetes mellitus in children and adolescents. Diagnostics, 10, 945. https://doi.org/10.3390/diagnostics10110945
Zajec, A., Trebušak Podkrajšek, K., Tesovnik, T., Šket, R., Čugalj Kern, B., Jenko Bizjan, B., Šmigoc Schweiger, D., Battelino, T. & Kovač, J. (2022). Pathogenesis of Type 1 Diabetes: Established Facts and New Insights. Genes, 13, 706. https://doi.org/10.3390/genes13040706
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Bushra Hussain Shnawa, Abdulsameea Majeed Taha
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License [CC BY-NC-SA 4.0] that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work, with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online.